Transmitted drug resistance mutations and trends of HIV-1 subtypes in treatment-naïve patients: A single-centre experience

Transmitted drug resistance mutations and trends of HIV-1 subtypes in treatment-naïve patients: A single-centre experience

Objectives: Transmitted drug resistance (TDR) and HIV-1 genetic diversity may affect treatment efficacy and clinical outcomes. Here we describe the circulating viral subtypes and estimate the prevalence of drug resistance among antiretroviral therapy (ART)-naïve patients attending Sapienza Universit...

Full description

Bibliographic Details
Main Authors:	Laura Mazzuti, Taulant Melengu, Francesca Falasca, Marianna Calabretto, Eleonora Cella, Massimo Ciccozzi, Ivano Mezzaroma, Giancarlo Iaiani, Martina Spaziante, Gabriella d’Ettorre, Caterina Fimiani, Vincenzo Vullo, Guido Antonelli, Ombretta Turriziani
Format:	Article
Language:	English
Published:	Elsevier 2020-03-01
Series:	Journal of Global Antimicrobial Resistance
Subjects:	Drug resistance mutation Transmitted drug resistance Antiretroviral-naïve HIV-1 subtype Integrase inhibitor resistance
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213716519302309

Similar Items

Resistance Analyses of Integrase Strand Transfer Inhibitors within Phase 3 Clinical Trials of Treatment-Naive Patients
by: Kirsten L. White, et al.
Published: (2014-07-01)

Dolutegravir Plus Lamivudine Two-Drug Regimen: Safety, Efficacy and Diagnostic Considerations for Its Use in Real-Life Clinical Practice—A Refined Approach in the COVID-19 Era
by: Valeria Cento, et al.
Published: (2021-04-01)

First Report of Drug Resistance against HIV-1 Integrase Inhibitors in Iran
by: Mohammad GHOLAMI, et al.
Published: (2019-04-01)

The study of susceptibility and resistance of HIV integrases to integrase strand transfer inhibitors and the development of novel single domain antibody targeting HIV integrase
by: Ni, Xiaoju
Published: (2011)

Prevalence of resistance to integrase strand-transfer inhibitors (INSTIs) among untreated HIV-1 infected patients in Morocco
by: Najwa Alaoui, et al.
Published: (2018-06-01)

Fitness Impaired Drug Resistant HIV-1 Is Not Compromised in Cell-to-Cell Transmission or Establishment of and Reactivation from Latency
by: Sophie M. Bastarache, et al.
Published: (2014-09-01)

Will Drug Resistance against Dolutegravir in Initial Therapy Ever Occur?
by: Mark eWainberg, et al.
Published: (2015-04-01)

HIV-1 integrase resistance among antiretroviral treatment naive and experienced patients from Northwestern Poland
by: Parczewski Miłosz, et al.
Published: (2012-12-01)

Detection of human immunodeficiency virus type 1 transmitted drug resistance among treatment-naive individuals residing in Jakarta, Indonesia
by: Siti Qamariyah Khairunisa, et al.
Published: (2020-07-01)

HIV-1 acquired drug resistance to integrase inhibitors in a cohort of antiretroviral therapy multi-experienced Mexican patients failing to raltegravir: a cross-sectional study
by: Aurelio Orta-Resendiz, et al.
Published: (2020-02-01)

Trend of HIV transmitted drug resistance before and after implementation of HAART regimen restriction in the treatment of HIV-1 infected patients in southern Taiwan
by: Ya-Wei Weng, et al.
Published: (2019-08-01)

A phase IV randomised, open-label pilot study to evaluate switching from protease-inhibitor based regimen to Bictegravir/Emtricitabine/Tenofovir Alafenamide single tablet regimen in Integrase inhibitor-naïve, virologically suppressed HIV-1 infected adults harbouring drug resistance mutations (PIBIK study): study protocol for a randomised trial
by: Collins C. Iwuji, et al.
Published: (2020-07-01)

The prevalence of drug resistance among treatment-naïve HIV-1-infected individuals in China during pre- and post- 2004
by: Hanping Li, et al.
Published: (2016-10-01)

Absence of Integrase Inhibitor-Associated Resistance Among Antiretroviral Therapy-Naïve HIV-1-Infected Adults in Guangdong Province, China, in 2018
by: Lan Y, et al.
Published: (2020-12-01)

Molecular evolution of HIV-1 integrase during the 20 years prior to the first approval of integrase inhibitors
by: Karolin Meixenberger, et al.
Published: (2017-11-01)

Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs
by: Bluma G. Brenner, et al.
Published: (2010-11-01)

High prevalence of HIV-1 transmitted drug resistance among therapy-naïve Burmese entering travelers at Dehong ports in Yunnan, China
by: Qicai Xuan, et al.
Published: (2018-05-01)

Molecular mechanism of HIV-1 integrase inhibition by Raltegravir proposed by using of molecular modeling approaches
by: Arora, Rohit
Published: (2012)

HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: a systematic review and meta-analysis protocol
by: Ezechiel Ngoufack Jagni Semengue, et al.
Published: (2020-04-01)

Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance
by: Eva Wolf, et al.
Published: (2021-09-01)

Transmitted drug resistance among HIV-1 drug-naïve patients in Greece
by: Maria Kantzanou, et al.
Published: (2021-04-01)

Rates and Correlates of Short Term Virologic Response among Treatment-Naïve HIV-Infected Children Initiating Antiretroviral Therapy in Ethiopia: A Multi-Center Prospective Cohort Study
by: Birkneh Tilahun Tadesse, et al.
Published: (2019-09-01)

First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens
by: Joseph Fokam, et al.
Published: (2020-08-01)

Prevalence of HIV-1 Integrase Strand Transfer Inhibitor Resistance in Treatment-Naïve Voluntary Counselling and Testing Clients by Population Sequencing and Illumina Next-Generation Sequencing in Taiwan
by: Tsai HC, et al.
Published: (2020-12-01)

Novel therapeutic strategies targeting HIV integrase
by: Quashie Peter K, et al.
Published: (2012-04-01)

Mechanism of action of allosteric HIV-1 integrase inhibitors
by: Slaughter, Alison Paige
Published: (2015)

Low Frequency of Integrase Inhibitor Resistance Mutations Among Therapy-Naïve HIV Patients in Southeast China
by: Lai J, et al.
Published: (2021-02-01)

Variability in HIV-1 Integrase Gene and 3′-Polypurine Tract Sequences in Cameroon Clinical Isolates, and Implications for Integrase Inhibitors Efficacy
by: Arpan Acharya, et al.
Published: (2020-02-01)

Structural Implications of Genotypic Variations in HIV-1 Integrase From Diverse Subtypes
by: Leonard Rogers, et al.
Published: (2018-08-01)

HIV-1 drug resistance genotyping from antiretroviral therapy (ART) naïve and first-line treatment failures in Djiboutian patients
by: Elmi Abar Aden, et al.
Published: (2012-10-01)

Evaluation of HIV-1 integrase resistance emergence and evolution in patients treated with integrase inhibitors
by: Rossana Scutari, et al.
Published: (2020-03-01)

HIV drug resistance among naïve HIV-infected patients in Iran
by: Molood Farrokhi, et al.
Published: (2019-01-01)

First and second line drug resistance among treatment naïve pulmonary tuberculosis patients in a district under Revised National Tuberculosis Control Programme (RNTCP) in New Delhi
by: Vithal Prasad Myneedu, et al.
Published: (2019-04-01)

The Occurrence of Integrase Genes in Different Stages of Wastewater Treatment
by: Martyna Buta, et al.
Published: (2019-11-01)

Development of a novel in vitro assay for the evaluation of integron DNA integrase activity
by: Fatemeh Tohidi, et al.
Published: (2016-05-01)

G140S/Q148R and N155H mutations render HIV-2 Integrase resistant to Raltegravir whereas Y143C does not
by: Damond Florence, et al.
Published: (2011-08-01)

Surveillance of transmitted HIV drug resistance among newly diagnosed, treatment-naive individuals at a county HIV clinic in Santa Clara County
by: William Chan, et al.
Published: (2019-09-01)

Increased HIV-1 pretreatment drug resistance with consistent clade homogeneity among ART-naive HIV-1 infected individuals in Ethiopia
by: Mulugeta Kiros, et al.
Published: (2020-09-01)

Coevolved Multidrug-Resistant HIV-1 Protease and Reverse Transcriptase Influences Integrase Drug Susceptibility and Replication Fitness
by: Supang A. Martin, et al.
Published: (2021-08-01)

Moderate rate of transmitted resistance mutations to antiretrovirals and genetic diversity in newly HIV-1 patients diagnosed in Benin
by: Edmond Tchiakpe, et al.
Published: (2020-07-01)